Cefotaxime
"Cefotaxime" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic broad-spectrum cephalosporin.
| Descriptor ID |
D002439
|
| MeSH Number(s) |
D02.065.589.099.249.190.190 D02.886.665.074.190.190 D04.075.080.875.099.221.249.190.190
|
| Concept/Terms |
Biosint- Biosint
- Liomont Brand of Cefotaxime Sodium
Cefradil- Cefradil
- Merck Brand of Cefotaxime Sodium
Taporin- Taporin
- Galen Brand of Cefotaxime Sodium
Fotexina- Fotexina
- Pisa Brand of Cefotaxime Sodium
Kendrick- Kendrick
- Viken Brand of Cefotaxime Sodium
Benaxima- Benaxima
- Fustery Brand of Cefotaxime Sodium
Claforan- Claforan
- Primafen
- Hoechst Brand of Cefotaxime Sodium
- Klaforan
- Aventis Brand of Cefotaxime Sodium
- Aventis Pharma Brand of Cefotaxime Sodium
|
Below are MeSH descriptors whose meaning is more general than "Cefotaxime".
Below are MeSH descriptors whose meaning is more specific than "Cefotaxime".
This graph shows the total number of publications written about "Cefotaxime" by people in this website by year, and whether "Cefotaxime" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 1 | 0 | 1 |
| 1985 | 1 | 0 | 1 |
| 1986 | 0 | 1 | 1 |
| 1989 | 1 | 0 | 1 |
| 1991 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cefotaxime" by people in Profiles.
-
Simon DM, Koenig G, Trenholme GM. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis. 1991 Oct; 164(4):800-2.
-
Trenholme GM, Schmitt BA, Nelson JA, Gvazdinskas LC, Harrison BB, Parkhurst GW. Comparative study of three different dosing regimens of cefotaxime for treatment of gram-negative bacteremia. Diagn Microbiol Infect Dis. 1989 Jan-Feb; 12(1):107-11.
-
Weinstein RA. Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect Control. 1986 Feb; 7(2 Suppl):120-3.
-
Weinstein RA. Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients. Chemioterapia. 1985 Feb; 4(1):110-2.
-
Karakusis PH, Feczko JM, Goodman LJ, Hanlon DM, Harris AA, Levin S, Trenholme GM. Clinical efficacy of cefotaxime in serious infections. Antimicrob Agents Chemother. 1982 Jan; 21(1):119-24.